-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

203.P1.23 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster I

Symposia: Lymphocytes and Acquired or Congenital Immunodeficiency Disorders Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Joshua D Brandstadter, MD, PhD, MSc1,2, Mechthild Lutge, PhD3*, Megan S Lim, MD, PhD4, Adam Bagg, MD5, Ira D. Miller, BS1*, Michael V. Gonzalez1*, Bridget Austin1*, Salvatore F. Priore, MD5*, Burkhard Ludewig, DVM3*, David C. Fajgenbaum, MD6 and Ivan Maillard, MD, PhD2

1Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
2Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
3Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland
4Memorial Sloan Kettering Cancer Center, New York City, NY
5School of Medicine, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
6Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA

Mateo Sarmiento Bustamante, BA1*, Criswell L. M. Lavery, BS, MPH1*, Adam Bagg, MD2, Mary Jo Lechowicz, MD3, Daisy V. Alapat, MD4, Amy Chadburn, MD5, Megan S Lim, MD, PhD6, Gordan Srkalovic, MD, PhD7, Frits van Rhee, MD, PhD8, Joshua D Brandstadter, MD, PhD, MSc1,9 and David C. Fajgenbaum, MD10

1Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
2School of Medicine, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
3Emory University, Winship Cancer Institute, Atlanta, GA
4Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR
5Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
6Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY
7Sparrow Herbert-Herman Cancer Center, University of Michigan Health, Lansing, MI
8Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
9Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
10Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA

Shuyu Shi1, Kathryn Lurain, MD, MPH2, Joseph G. Schroers-Martin, MD3, Andrea Garofalo, BS, BA4, Jurik A. Mutter, PhD4*, Takeshi Sugio, MD, PhD4*, Xiaoman Kang, BS5*, Feng Tian, PhD4*, Chih Long Liu, PhD4*, Mari Olsen, BS4*, Wyndham H. Wilson, MD, PhD6*, Maximilian Diehn, MD, PhD7*, Mark Roschewski, MD8 and Ash A. Alizadeh, MD, PhD4

1Dept. of Bioengineering, Schools of Engineering and Medicine, Stanford, CA
2HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD
3Department of Medicine, Division of Oncology and Hematology, Stanford University, Menlo Park, CA
4Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
5Department of Medicine, Division of Oncology, Stanford University, Stanford, CA
6Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
7Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA
8National Cancer Institute, Bethesda, MD

Shaikha Alqahtani, MD1*, Fabiana Cacace1,2*, Taylor McMichael, MSN, RN, CPNP-AC1*, Emily Dodd, BSN, RN1*, Elizabeth McCarthy, RN, MSN3*, Andrea Bauchat, DO1*, Timothy A. Driscoll1*, Paul L. Martin, MD, PhD1, Carmem Bonfim, MD, PhD1*, John Sleasman, MD3* and Kris Michael Mahadeo, MD1

1Pediatric Transplantation and Cellular Therapy, Duke University, Durham, NC
2Stem Cell Transplantation and Cell Therapy Unit, AORN Santobono Pausilipon, Naples, Italy
3Pediatric Allergy Immunology, Duke University, Durham, NC

Emily Landy, PhD1*, Melissa Mavers2,3*, Reyka G. Jayasinghe, PhD4,5*, Nathan Schedler, BS6* and Robert S. Negrin, MD7

1Washington University in St. Louis, Chesterfield, MO
2Department of Pediatrics, Division of Hematology / Oncology, Washington University School of Medicine, Saint Louis, MO
3Department of Pediatrics, Division of Hematology and Oncology, Washington University School of Medicine, St. Louis, MO
4Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University, Saint Louis, MO
5Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO
6School of Medicine, Wake Forest University, Winston-Salem, NC
7Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA

Zhe Lu1*, Olivia Stencel2*, Wei Liu3,4*, Eleni Vasileiou2*, Haifeng Chris Xu5*, Piyush Pandey5*, Pawel Stachura2*, Abdelrahman Elwy6*, Anastassia Tsombal2*, Ann-Sophie Mai3,4*, Auer Franziska7*, Mina Morcos7*, Maximilian Seidl8*, Sarah Elitzur, MD9, Gunther Hartmann3,4*, Karl Sebastian Lang6*, Stefan Janssen10*, Sanil Bhatia11*, Philipp Lang5*, Ute Fischer11*, Julia Hauer12,13*, Arndt Borkhardt2 and Aleksandra A. Pandyra3,4,11*

1Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University Düsseldorf, Dusseldorf, AL, Germany
2Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University Düsseldorf, Duesseldorf, Germany
3Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany
4German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany
5Department of Molecular Medicine II, Medical Faculty, Heinrich Heine University Düsseldorf, Duesseldorf, Germany
6Institute of Immunology, Medical Faculty, University of Duisburg-Essen, Essen, Germany
7Department of Pediatrics,School of Medicine,Technical University of Munich, Munich, Germany
8Institute of Pathology, Medical Faculty, Heinrich Heine University Düsseldorf, Duesseldorf, Germany
9Schneider Children's Medical Center, Petah Tikva, Israel
10Algorithmic Bioinformatics, Department of Biology and Chemistry, Justus Liebig University, Giessen, Germany
11Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
12Department of Pediatrics, Children's Cancer Research Center, Kinderklinik München Schwabing, Munich, Germany
13German Center for Child and Adolescent Health (DZKJ), partner site Munich, Munich, Germany

Jiexian Ma1*, Xinyuan Ma2*, Xinyu Zuo1* and Shuhong Shen3

1Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China
2Fudan University, Shanghai, AL, China
3Department of Hematology , Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Jianing Ren1*, Yang Wan, MD PhD2*, Yang Lan3*, Xiaolan Li4*, Jun Li3*, Li Zhang3*, Yumei Chen4*, Tianfeng Liu3*, Wenyu Yang, MD4* and Xiaofan Zhu, MD4

1TianJin Medical University,Haihe Laboratory of Cell Ecosystem, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
4Department of Pediatric Hematology and Oncology, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences& Peking Union Medical College, Tianjin, China

Eleni Gavriilaki, MD, PhD1,2, Despina Mallouri, MD3*, Ioannis Batsis, MD1*, Zoi Bousiou, MD1*, Anna Vardi, MD1*, Nikolaos Spyridis, MD4*, Georgios Karavalakis, MD4*, Alkistis Kyra Panteliadou, MD4*, Panagiotis Dolgyras, MD1*, Christos Varelas, MD4*, Vlasios I Alevizopoulos5*, Panagiotis Asteris6*, Panayiotis Vlachoyiannopoulos7*, Evangelia Yannaki, MD4*, Damianos Sotiropoulos, MD1 and Ioanna Sakellari8*

1Hematology Department – BMT Unit, George Papanikolaou General Hospital, Thessaloniki, Greece
2Aristotle University of Thessaloniki, Thessaloniki, Greece
3German Oncology Center, Hematology Department, Limassol, Cyprus
4Hematology Department – BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece
52nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
6Computational Mechanics Laboratory, School of Pedagogical and Technological Education, Athens, Greece
7Department of Pathophysiology, School of Medicine, National University of Athens, Athens, Greece
8Hematology Department – BMT Unit, G Papanikolaou Hospital, Thessaloniki, Greece

*signifies non-member of ASH